Kiran Mazumdar Shaw, CMD of Biocon said their branded formulation business has grown 45 percent and excluding it the bio pharma business has seen 20 percent growth year-on-year. She also feels the business is gaining traction in emerging markets and the US.
first published: Oct 31, 2012 12:24 pm
A collection of the most-viewed Moneycontrol videos.
Crude Prices Stay High; Talks To Reopen Strait of Hormuz | Trump Tariffs Under Fire | Opening Bell
Live: Nifty snaps 3-day losing streak as markets shake off war jitters | Closing Bell
Trump Plans To Secure Strait Of Hormuz, Weighs U.S. Role Post Iran War: White House
Putin Hints At Cutting Gas Supply To Europe, Eyes New Profitable Markets
